Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients

This publication has 27 references indexed in Scilit:

• French phase III trial of preoperative chemotherapy (PCT) in resectable stage I (except T1N0), II, IIIa non-small cell lung cancer (NSCLC)
  Lung Cancer, 2000
• Conditional Survival Among Patients With Carcinoma of the Lung
  Chest, 1999
• Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 1999
• Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party
  European Journal Of Cancer, 1997
• Revisions in the International System for Staging Lung Cancer
  Chest, 1997
• Prognostic value of histology in patients with non-small cell lung cancer
  Lung Cancer, 1997
• Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: Correlation with TNM stage and disease free and overall survival
  Cancer, 1996
• CEA, CYFRA21-1 and SCC in non-small cell lung cancer
  Lung Cancer, 1995
• Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung Cancer
  Chest, 1995
• Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433
  Lung Cancer, 1993